AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)---- $AKRO #AKRO--Robbins LLP is Investigating Allegations Akero Therapeutics, Inc. (AKRO) Misled Investors Regarding Viability and Efficacy of its Trial Drug Candidate